![]() |
|
|
Oct 17, 2009: GENDIA now offers a next-generation sequencing platform for the molecular diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) with complete sequencing of the following 2 genes:
Once a disease-causing mutation is identified, family members can be screened for that mutation at 250 Euro. The turnaround time of the test is 3 months. More.. |